BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 34702305)

  • 1. Cone beam CT-based dose accumulation and analysis of delivered dose to the dominant intraprostatic lesion in primary radiotherapy of prostate cancer.
    Tamihardja J; Cirsi S; Kessler P; Razinskas G; Exner F; Richter A; Polat B; Flentje M
    Radiat Oncol; 2021 Oct; 16(1):205. PubMed ID: 34702305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dominant intraprostatic lesion boosting in sexual-sparing radiotherapy of prostate cancer: A planning feasibility study.
    Ciabatti S; Ntreta M; Buwenge M; Gaudiano C; Sessagesimi E; Romani F; Angelini AL; Cammelli S; Macchia G; Deodato F; Zamagni A; Golfieri R; Morganti AG; Cilla S
    Med Dosim; 2019 Winter; 44(4):356-364. PubMed ID: 30955990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of the delivered dose based on cone-beam CT and deformable image registration for non-small cell lung cancer treated with hypofractionated radiotherapy.
    Wang B; Wang DQ; Lin MS; Lu SP; Zhang J; Chen L; Li QW; Cheng ZK; Liu FJ; Guo JY; Liu H; Qiu B
    BMC Cancer; 2020 Nov; 20(1):1112. PubMed ID: 33198676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between volume changes and spatial dose metrics for the urinary bladder during local versus pelvic irradiation for prostate cancer.
    Casares-Magaz O; Moiseenko V; Hopper A; Pettersson NJ; Thor M; Knopp R; Deasy JO; Muren LP; Einck J
    Acta Oncol; 2017 Jun; 56(6):884-890. PubMed ID: 28401808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parotid gland radiation dose-xerostomia relationships based on actual delivered dose for nasopharyngeal carcinoma.
    Lou J; Huang P; Ma C; Zheng Y; Chen J; Liang Y; Li H; Yin Y; Liu D; Yu G; Li D
    J Appl Clin Med Phys; 2018 May; 19(3):251-260. PubMed ID: 29664218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate stereotactic ablative radiation therapy using volumetric modulated arc therapy to dominant intraprostatic lesions.
    Murray LJ; Lilley J; Thompson CM; Cosgrove V; Mason J; Sykes J; Franks K; Sebag-Montefiore D; Henry AM
    Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):406-15. PubMed ID: 24685447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric and volumetric changes in the rectum and bladder in patients receiving CBCT-guided prostate IMRT: analysis based on daily CBCT dose calculation.
    Pearson D; Gill SK; Campbell N; Reddy K
    J Appl Clin Med Phys; 2016 Nov; 17(6):107-117. PubMed ID: 27929486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of online/offline image guidance/adaptation approaches for prostate cancer radiation therapy.
    Qin A; Sun Y; Liang J; Yan D
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1026-33. PubMed ID: 25832693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI-guided localization of the dominant intraprostatic lesion and dose analysis of volumetric modulated arc therapy planning for prostate cancer.
    Tamihardja J; Zenk M; Flentje M
    Strahlenther Onkol; 2019 Feb; 195(2):145-152. PubMed ID: 30209535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the dosimetric influence of interfractional 6D setup error in hypofractionated prostate cancer treated with IMRT and VMAT using daily kV-CBCT.
    Shinde P; Jadhav A; Shankar V; Dhoble SJ
    J Med Imaging Radiat Sci; 2022 Dec; 53(4):693-703. PubMed ID: 36289030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect on therapeutic ratio of planning a boosted radiotherapy dose to the dominant intraprostatic tumour lesion within the prostate based on multifunctional MR parameters.
    Riches SF; Payne GS; Desouza NM; Dearnaley D; Morgan VA; Morgan SC; Partridge M
    Br J Radiol; 2014 May; 87(1037):20130813. PubMed ID: 24601648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI.
    van Lin EN; Fütterer JJ; Heijmink SW; van der Vight LP; Hoffmann AL; van Kollenburg P; Huisman HJ; Scheenen TW; Witjes JA; Leer JW; Barentsz JO; Visser AG
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):291-303. PubMed ID: 16618584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of Conebeam CT-based online adaptive radiotherapy for neoadjuvant treatment of rectal cancer.
    de Jong R; Visser J; van Wieringen N; Wiersma J; Geijsen D; Bel A
    Radiat Oncol; 2021 Jul; 16(1):136. PubMed ID: 34301300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Megavoltage cone beam computed tomography dose and the necessity of reoptimization for imaging dose-integrated intensity-modulated radiotherapy for prostate cancer.
    Akino Y; Koizumi M; Sumida I; Takahashi Y; Ogata T; Ota S; Isohashi F; Konishi K; Yoshioka Y
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1715-22. PubMed ID: 21620584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Dose of the day" based on cone beam computed tomography and deformable image registration for lung cancer radiotherapy.
    Yuan Z; Rong Y; Benedict SH; Daly ME; Qiu J; Yamamoto T
    J Appl Clin Med Phys; 2020 Jan; 21(1):88-94. PubMed ID: 31816170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of dosimetric variations of liver radiotherapy using deformable registration of planning CT and cone-beam CT.
    Huang P; Yu G; Chen J; Ma C; Qin S; Yin Y; Liang Y; Li H; Li D
    J Appl Clin Med Phys; 2017 Jan; 18(1):66-75. PubMed ID: 28291931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of on-board kV cone beam computed tomography-based dose calculation with deformable image registration using Hounsfield unit modifications.
    Onozato Y; Kadoya N; Fujita Y; Arai K; Dobashi S; Takeda K; Kishi K; Umezawa R; Matsushita H; Jingu K
    Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):416-23. PubMed ID: 24685445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-time adaptive planning method for radiotherapy treatment delivery for prostate cancer patients, based on a library of plans accounting for possible anatomy configuration changes.
    Antico M; Prinsen P; Cellini F; Fracassi A; Isola AA; Cobben D; Fontanarosa D
    PLoS One; 2019; 14(2):e0213002. PubMed ID: 30818345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of the margin required for treating intraprostatic lesions.
    Studenski MT; Valenciaga Y; Abramowitz MC; Stoyanova R; Bossart E; Dogan N; Pollack A
    J Appl Clin Med Phys; 2016 May; 17(3):304-312. PubMed ID: 27167286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric effect of online image-guided anatomical interventions for postprostatectomy cancer patients.
    Diot Q; Olsen C; Kavanagh B; Raben D; Miften M
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):623-32. PubMed ID: 20643519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.